B ackground: The degree of spreading of Hodgkin' s lymphoma (HL) is usually estimated according to An Arbor classification system and its modifications. Some laboratory parameters are routinely determined at diagnosis and their abnormal values tries to correlate with disease activity or extension. Objectives of the research were to identify relationship between common laboratory parameters used in patients with HL, with focus on Serum copper level (SCL) and the degree of spreading of disease expressed through clinical stage (CS). Materials and Methods. Research was carried out through retrospective analysis of medical records of 47 previously untreated HL patients. The study evaluated descriptive statistical parameters, mean, median, standard deviation, minimum and maximum values, ANOVA, X 2 test, Man-Whitney test and Spearman' s correlation. Statistical analyzes performed using SPSS statistical software v.13.0. Results have presented in form of tables and graphs. Significance level less than 0.05 considered significant. Results. The results of study shown good sensitivity of SCL (61,9%), and very high specificity (95,3%) in diagnosis of HL. PPV of SCL in our study was 92,9%, and NPV -71,9%. On the other hand, the results did not confirm correlation between serum copper level and spreading of disease. Serum levels of albumin, gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) showed good correlation with clinical stage. Conclusion: Our results did not confirm significance of serum copper level in term of staging of HL. Sensitivity and significance of serum copper in HL was very good and real prognostic impact of its elevated level in these patients should be assessed, and the research conducted on a larger number of subjects.
INTRODUCTION
Hodgkin's lymphoma is typically present by painless peripheral lymphatics magnification, and constitutional symptoms (sweating, unexplained weight loss or fever, itchy skin). The disease may also have extranodal localization.
Classification. According to current classification of the World Health Organization (WHO), there are two main groups of HL: "Nodular lymphocyte predominance type" (NLP), which is different from "Classical HL" (CHL) in terms of morphology, phenotype, clinical presentation and behavior. Classical HL, includes four subtypes: nodular sclerosis type (NS), lymphocyte-rich type (LP), lymphocyte depletion (LD), and Mixed cellularity (MC). (1, 2) .
Epidemiology. In Western countries, incidence of HL is estimated to be around 3/100000 per year. The disease is twice as common in men, while in the adolescent period is equal in both sexes (3) . Most of the cases-about 95% are CHL, while NLP type accounts only 4-5% of cases. CHL shows bimodal age distribution with first peak in third and second peak in the seventh decade of life, while distribution of NLP is unimodal with peak in a fourth decade of life (1, 2) .
Etiopathogenesis of HL. Exact etiopathogenesis has not fully understood so far. HL cells generally represent malignant B cells modified with a specific histologic presentation in the form of Hodgkin's and Reed-Sternberg cells, which arise in the area of clonal rearrangements of the immunoglobulin heavy chain locus. Epstein-Barr virus (EBV) is associated with the emergence of HL, at least in some patients. (1, 3) .
Clinical presentation. The disease usually presents with painless lymph nodes magnification, usually in the neck, supraclavicular region, mediastinum, or other regions. Some patients have constitutional symptoms (1, 3) . In addition, virtually all organs and tissues could be affected by HL, including a bone marrow.
Diagnostics. Diagnosis of HL is mostly established by lymphatic node biopsy, enhanced by immunohistochemical markers (4) . Histopathological feature of HL is presence of Hodgkin's cells and significance of Copper Level in serum and routine Laboratory Parameters in estimation of Outspreading of hodgkin's Lymphoma Reed Sternberg (RS) cells, although these cells quantitatively represent a minority of cellular elements and often accounts about 1% of total cellular substrate in HL. Most of the cells represent "non-neoplastic" population composed from B and T lymphocytes, macrophages, eosinophils, basophils and plasma cells (1, 5, 6) .
Furthermore, as the knowledge of tumor biology has progressed, classification of lymphomas became more complicated and has recognized variety of different transitional forms of diseases between HL and certain types of Non Hodgkin's lymphomas. These forms often require different treatment than conventional protocols used in treatment of HL (7) .
Prognostic aspects. Prognosis of patients with HL has significantly improved in the last 20 years, so it is now considered a curable disease in more than 80% of cases (5) .
Staging. In defining of stage of disease traditionally is used An Arbor classification system or its modifications. In attempt to define the forms of advanced, unfavorable HL, International prognostic score (IPS) has recently proved useful. It takes into account age, clinical stage, serum albumin, hemoglobin, gender, leukocytosis and lymphocytopenia (8) .
The significance of the IPS has confirmed in independent researches, but it was originally designed mainly for patients with advanced forms of disease (5).
OBJeCTIVeS
The aim of study was to compare values of commonly used laboratory parameters with clinical stage in previously untreated HL patients with special reference to SCL.
MATeRIALS AND MeTHODS
Research was carried out by retrospective analysis of data of 47 patients with newly diagnosed HL. For comparison, serum coper level of 43 subjects with benign lymphadenopathy assessed. Blood samples (2 ml) have taken by cubital vein puncture, according to standard procedure of blood sampling, with 1 ml of blood. Quantitative SCL has been examined by using the method of spectrofotometry, on "Architect Ci8200" (Abbot). The results of SCL and other routine laboratory parameters correlated with clinical stage of HL according to An Arbor staging.Values of other routine laboratory tests -erythrocyte sedimentation rate (ESR), Leukocytes (Lkc), Neutrophiles (Neu), lymphocytes (Ly), hemoglobin (Hgb), gamma-glutamil transferase (GGT), alcaline phosphatase (ALP), and serum albumine-were also examined, and sampling performed by standard technic. For assessment of diagnostic significance of SCL in patients with confirmed HL, ROC curve calculations employed. Optimal cut off values of serum copper level determined when sensitivity and specificity were maximal. Statistical analyzes performed using SPSS statistical software v.13.0. Significance level less than 0.05 considered significant.
ReSULTS
Number of male and female subjects in the HL group was approximate: 19 vs. 28 (x 2 = 1.723, p = 0.189). Age analysis of tested group of patients at diagnosis showed the peak in younger age, i.e. distribution is bimodal (median 31 years (25.5 to 48.5), which corresponds to the literature data. Histopathological analysis find nodular sclerosis as most frequent type, followed by mixed cellularity. For rest of patients in sample, the exact subtype has not known, whereas we did not have rare forms of HL in the study sample. There was no statistically significant association between sex and subtype of HL (x 2 = 0.228, p=0.892). Man-Whitney test revealed no significant difference between gender and clinical stage (CS) (p=0.187), and between subtypes of HL and serum copper level (p=0.073). Sensitivity of SCL was 61,9%; specificity of SCL was very high -95,3%. PPV of SCL in our study was 92,9%, and NPV -71,9%. Cut off determined by using ROC curve (receiver operating curve) analysis for SCL in diagnostics of HL was at value 25,04.
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DISCUSSION
According to literature data, total six-year survival in early stage of HL (I and II) is about 90%, and in patients with advanced stages (III and IV)-almost 85%. However, there are still about 10% of patients with refractory HL and the other 10-15% who relapse and require more intensive treatment (6) . Efforts have been made to adequately define this high-risk group. In evaluating of disease stage-classification of disease advance according to An Arbor system is most commonly used. Abnormal values of routinely used laboratory parameters, seems to be associated with advance stage of disease. Serum concentrations of some oligoelements and other laboratory parameters in various malignancies have tried to connect to activity of neoplastic diseases, degree of spreading, worse course and worse outcome. In earlier small study of Fisher et al. relationship between serum concentrations of copper and zinc are consider significant in discrimination of primary and metastatic osteosarcoma (9) . Other authors suggested that serum concentration of copper, and the copper / zinc ratio may be predictors of successful treatment in patients with lymphoma (10, 11, 12) . In a study of Asbjornsen conducted on 54 HL patients, it was observed that serum copper level showed similar results as the erythrocyte sedimentation rate, i.e. both tests were significantly elevated in patients with active disease than in patients in remission (13) . The study of Cunzhi and collaborators conducted on 135 patients with HL and 100 healthy volunteers showed that the serum copper/zinc ratio is significantly higher, and serum zinc level lower in HL patients in comparison with healthy volunteers. This relationship is also more jarring in the progression of the disease, while the trend was reversed during remission. There was also difference in serum copper concentration in different histological subtypes of HL (14) . Martinow et al found that patients with elevated erythrocyte sedimentation rate, alkaline phosphatase, serum copper and urinary excretion of nucleosides are significantly less likely to achieve complete remission, maintain complete remission and has a lower probability of survival at ten years of monitoring; However, results showed that mentioned parameters are associated with stage of the disease and constitutional symptoms, and are not independent prognostic factors (15). Significance of serum copper level in HL in combination with erythrocyte sedimentation rate and prognostic value of serum iron and ceruloplasmin have also been examined (16, 17, 18) . In our study, we found no statistically significant correlation between ESR and CS of HL at diagnosis. Similar results obtained with leukocyte count, neutrophil percentage, and the percentage of lymphocytes as well as hemoglobin values. On the other hand, the same analysis found a moderate correlation between CS of HL and serum levels of GGT and ALP, as well as serum albumin. Further analysis correlated serum copper level with CS of HL shown no significant association. There was no statistically significant difference in serum copper level at diagnosis in relation to sex. Study did not test sensitivity and specificity of parameters investigated other than SCL.
CONCLUSION
The results of study do not support the importance of serum copper level in staging of HL. Furthermore, sensitivity and specificity of serum copper level in diagnosis of HL was very good and real prognostic impact of its elevated level in these patients should be assessed and research conducted on larger number of subjects.
